Ulcerative Colitis Clinical Trials

Showing 3201-3220 of 4,613 trials

Prevalence of Oral Mucosal Alterations in Mucocutaneous Ocular Disorders

NCT03679988

The patients will be selected from the pool of the Clinics (Rheumatology, Ophthalmology and Dermatology) of Faculty of Medicine and (Diagnostic center and Oral Medicine) of Faculty of Dentistry -Cairo University. For each eligible participant, a full history will be obtained followed by thorough clinical examination.

Oral DiseaseMuco-Cutaneo-Ocular Syndrome

Sherin Alaa Eldin Eisa Elsayed380 participantsStarted Oct 2018

UNKNOWN

Artificial Intelligence-assisted Glaucoma Screening (AIAGS)

NCT03682783

This study will develop an artificial intelligence (AI) program for the screening of glaucoma.

Glaucoma Eye

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine8,000 participantsStarted Oct 2018

Shanghai, Shanghai Municipality, China

COMPLETEDPhase 1

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

NCT02262338

AGT-182 is a fusion protein containing idursulfase that is intended to deliver the enzyme peripherally and to the brain, when administered intravenously. This study is a safety and dose ranging study to obtain safety and exposure data, as well as information on the biological activity of the investigational drug.

Mucopolysaccharidosis II

ArmaGen, Inc6 participantsStarted Apr 2015

Oakland, California, United States • Orange, California, United States • Decatur, Georgia, United States +2 more locations

UNKNOWNNA

Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device

NCT03611244

This study will be conducted without blind method. The portable seat device devised to maintain lumbar lordosis will be made within 1 year after the loss of ambulation in the participants with Duchenne muscular dystrophy with prospective design. In the control group, the presence of scoliosis will be calculated 5 years after the loss of ambulation in participants with Duchenne muscular dystrophy through analysis of retrospective medical records who had not been applied the portable seat device.

Scoliosis NeuromuscularDuchenne Muscular DystrophyLordosis Lumbar

Seoul National University Hospital98 participantsStarted Aug 2018

Seoul, South Korea • Seoul, South Korea

Prevalence of Oral Mucosal Alterations in Mucocutaneous Ocular Disorders

Artificial Intelligence-assisted Glaucoma Screening (AIAGS)

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device

Related Searches

IBD Self-management Website and Home Faecal Calprotectin Monitoring

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients

Risk Factor of Anterior Cruciate Ligament Rupture After Ligamentoplasty : What is the Importance of a Relative Deficit of Contralateral Hamstrings Assessed by Isokinetic in Postoperative ?

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

The Effect of Tooth Position During Orthodontic Treatment on the Apnea/ Hypopnea Index (AHI)

TranQuill™ Sling Snoreplasty for Snoring and Mild Obstructive Sleep Apnea:

Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement

Minimal Important Difference for the Glittre-ADL Test and London Chest Activity of Daily Living Scale

Impact of Early Respiratory Rehabilitation in the Exacerbations of Re-admitted COPD Patients

Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea

A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))

Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy

HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)